President Trump Signs Executive Order to Fast-Track Psychedelic Therapies for Veterans
On April 18, 2026, President Trump signed an executive order aimed at expediting the review of psychedelic therapies, such as ibogaine, for veterans suffering from PTSD, traumatic brain injuries, and addiction. The order directs the FDA to fast-track these treatments and allocates $50 million in federal funding to expand access. This move is in response to the high rate of veteran suicides, which Trump highlighted as being 21 times higher than battlefield deaths since 9/11. The decision follows a 2024 Stanford University study that showed significant improvements in veterans' mental health after a single ibogaine session, with no serious side effects reported. The treatment, currently available in Mexico, has been sought by many veterans due to its promising results.